Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.278
-0.002 (-0.68%)
At close: Apr 28, 2026, 4:00 PM EDT
0.284
+0.006 (2.01%)
After-hours: Apr 28, 2026, 4:31 PM EDT
Mereo BioPharma Group Employees
Mereo BioPharma Group had 39 employees as of December 31, 2025. The number of employees increased by 3 or 8.33% compared to the previous year.
Employees
39
Change (1Y)
3
Growth (1Y)
8.33%
Revenue / Employee
$12,821
Profits / Employee
-$1,073,795
Market Cap
43.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 76 |
| Plus Therapeutics | 28 |
| Atossa Therapeutics | 16 |
| Rallybio | 14 |
| Nutriband | 13 |
| Rein Therapeutics | 10 |
| Hyperion DeFi | 9 |
| Dogwood Therapeutics | 8 |
MREO News
- 22 days ago - Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky - GlobeNewsWire
- 22 days ago - MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO - GlobeNewsWire
- 22 days ago - MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO - Newsfile Corp
- 22 days ago - MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights - GlobeNewsWire
- 22 days ago - MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 - Business Wire
- 22 days ago - Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO - PRNewsWire
- 22 days ago - MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm - PRNewsWire
- 22 days ago - MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit - PRNewsWire